Osteoblast-Adhesive Peptide |
| Catalog No.GA23325 |
KRSR selectively enhanced heparan sulfate-mediated osteoblast adhesion mechanisms. Elucidating such peptide sequence is of importance to the field of bone-cell/tissue engineering as well as to the design of proactive dental/orthopedic biomaterials. Note: Uses of this peptide are covered by U.S. Patent No. 6,262,017 B1 owned by Rensselaer Polytechnic Institute (RPI) located in Troy, New York, U.S.A. RPI authorizes purchasers of 5 grams or less per year to use this peptide for research purposes only. Other purchasers must have a written licence from RPI.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 193613-75-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
KRSR selectively enhanced heparan sulfate-mediated osteoblast adhesion mechanisms. Elucidating such peptide sequence is of importance to the field of bone-cell/tissue engineering as well as to the design of proactive dental/orthopedic biomaterials.Note
Average Rating: 5 (Based on Reviews and 32 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *